Dinesh Kadariya, M.B.B.S. (M.D.)

Dinesh Kadariya M.B.B.S. (M.D.)

Assistant Professor

Department: Department of Medicine
Business Phone: (904) 244-2655
Business Email: Dinesh.Kadariya@jax.ufl.edu

Board Certifications

  • Internal Medicine

Clinical Profile

Specialties
  • Cardiovascular Disease
Interests
  • Clinical Special Interests: Cardiovascular diseases, non-invasive cardiology, multimodality imaging
  • Research Special Interests: Anti-inflammatory therapy in cardiovascular disease, heartfailure, cardiopulmonary exercise

Publications

2022
Comparison of Cardiorespiratory Fitness in Black or African American Versus Caucasian Patients With Heart Failure.
Journal of cardiopulmonary rehabilitation and prevention.42(1):39-44[DOI] 10.1097/HCR.0000000000000605.[PMID] 34793367.
2022
Early changes in N-terminal pro-brain natriuretic peptide levels predict new-onset heart failure in patients with STEMI.
Minerva cardiology and angiology.70(1):25-31[DOI] 10.23736/S2724-5683.20.05303-7.[PMID] 32657561.
2022
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction.
Scientific reports.12(1):1254-[DOI] 10.1038/s41598-022-05374-w.[PMID] 35075216.
2022
Influence of extracellular volume fraction on peak exercise oxygen pulse following thoracic radiotherapy.
Cardio-oncology (London, England).8(1):1-[DOI] 10.1186/s40959-021-00127-6.[PMID] 35042565.
2022
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.
European heart journal. Cardiovascular pharmacotherapy.8(5):503-510[DOI] 10.1093/ehjcvp/pvab075.[PMID] 34617567.
2022
Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.
International journal of cardiology.355():23-27[DOI] 10.1016/j.ijcard.2022.03.010.[PMID] 35276244.
2022
Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure.
The American journal of cardiology.174():61-67[DOI] 10.1016/j.amjcard.2022.03.026.[PMID] 35473780.
2022
Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction.
Journal of cardiovascular pharmacology.80(5):672-678[DOI] 10.1097/FJC.0000000000001331.[PMID] 35881895.
2021
A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.
PloS one.16(5):e0247357-[DOI] 10.1371/journal.pone.0247357.[PMID] 33956804.
2021
Clinical features and outcomes between African American and Caucasian patients with Takotsubo Syndrome.
Minerva cardiology and angiology.69(6):750-759[DOI] 10.23736/S2724-5683.20.05456-0.[PMID] 33427424.
2021
Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus.
Journal of the American Heart Association.10(8):e018631-[DOI] 10.1161/JAHA.120.018631.[PMID] 33825487.
2021
Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF Study.
Journal of cardiovascular pharmacology.78(3):407-410[DOI] 10.1097/FJC.0000000000001083.[PMID] 34132690.
2021
Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience.
Cardio-oncology (London, England).7(1):40-[DOI] 10.1186/s40959-021-00126-7.[PMID] 34847948.
2021
The Chronic Kidney Disease Phenotype of HFpEF: Unique Cardiac Characteristics.
The American journal of cardiology.142():143-145[DOI] 10.1016/j.amjcard.2020.12.012.[PMID] 33333073.
2021
Time of eating and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction and obesity.
Nutrition, metabolism, and cardiovascular diseases : NMCD.31(8):2471-2473[DOI] 10.1016/j.numecd.2021.04.018.[PMID] 34112580.
2020
Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
Journal of cardiovascular pharmacology.76(1):50-52[DOI] 10.1097/FJC.0000000000000847.[PMID] 32398478.
2020
Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors.
The American journal of cardiology.125(6):988-996[DOI] 10.1016/j.amjcard.2019.12.019.[PMID] 31928717.
2020
Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions.
The American journal of cardiology.125(1):76-81[DOI] 10.1016/j.amjcard.2019.09.036.[PMID] 31703805.
2020
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
Journal of the American Heart Association.9(5):e014941-[DOI] 10.1161/JAHA.119.014941.[PMID] 32122219.
2020
Peak Oxygen Uptake Recovery Delay After Maximal Exercise in Patients With Heart Failure.
Journal of cardiopulmonary rehabilitation and prevention.40(6):434-437[DOI] 10.1097/HCR.0000000000000502.[PMID] 32332250.
2020
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure.
Journal of cardiovascular pharmacology.77(1):49-60[DOI] 10.1097/FJC.0000000000000931.[PMID] 33235030.
2020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study.
Diabetes/metabolism research and reviews.36(8):e3335-[DOI] 10.1002/dmrr.3335.[PMID] 32415802.
2019
Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).
Journal of cardiovascular pharmacology.74(3):266-269[DOI] 10.1097/FJC.0000000000000706.[PMID] 31356537.
2019
Association of Anti-Mullerian Hormone with C-Reactive Protein in Men.
Scientific reports.9(1):13081-[DOI] 10.1038/s41598-019-49596-x.[PMID] 31511566.
2019
IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.
American journal of respiratory and critical care medicine.199(3):381-384[DOI] 10.1164/rccm.201809-1631LE.[PMID] 30418047.
2019
Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder.
Journal of cardiovascular pharmacology.74(6):528-534[DOI] 10.1097/FJC.0000000000000740.[PMID] 31809403.
2019
Potential role for interleukin-1 in the cardio-renal syndrome.
European journal of heart failure.21(3):385-386[DOI] 10.1002/ejhf.1403.[PMID] 30666820.
2019
Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.
The American journal of cardiology.123(3):466-473[DOI] 10.1016/j.amjcard.2018.10.027.[PMID] 30502049.
2019
Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study.
JACC. Basic to translational science.4(4):563-565[DOI] 10.1016/j.jacbts.2019.04.001.[PMID] 31468011.
2018
C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction.
Frontiers in cardiovascular medicine.5():178-[DOI] 10.3389/fcvm.2018.00178.[PMID] 30619885.
2018
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials.
Journal of cardiovascular pharmacology.72(1):68-70[DOI] 10.1097/FJC.0000000000000591.[PMID] 29738374.
2018
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.
Diabetes, obesity & metabolism.20(8):2014-2018[DOI] 10.1111/dom.13309.[PMID] 29603546.
2018
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
Circulation. Heart failure.11(8):e005036-[DOI] 10.1161/CIRCHEARTFAILURE.118.005036.[PMID] 30354558.
2018
Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.
ESC heart failure.5(2):372-378[DOI] 10.1002/ehf2.12235.[PMID] 29345112.
2018
Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.
Clinical cardiology.41(8):1004-1008[DOI] 10.1002/clc.22988.[PMID] 30033595.
2018
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.
The American journal of cardiology.122(8):1366-1370[DOI] 10.1016/j.amjcard.2018.07.002.[PMID] 30244844.
2017
Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up.
Drug design, development and therapy.11():2121-2129[DOI] 10.2147/DDDT.S114091.[PMID] 28744103.
2017
Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction.
JACC. Basic to translational science.2(5):513-525[DOI] 10.1016/j.jacbts.2017.06.009.[PMID] 30062167.
2017
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
Circulation. Heart failure.10(11):-[DOI] 10.1161/CIRCHEARTFAILURE.117.004373.[PMID] 29141858.
2017
Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure.
The American journal of cardiology.120(10):1854-1857[DOI] 10.1016/j.amjcard.2017.07.099.[PMID] 28867128.

Office Information

Academic Office
5th Floor, Ambulatory Care Center
655 West 8th Street, C35
Jacksonville, FL 32209
(904) 244-2655
Dinesh.Kadariya@jax.ufl.edu
Administrative Manager
Erika Jackson
(904) 244-2655
erika.jackson@jax.ufl.edu

Education

Medical Degree
2006 · -Nalanda Medical College & Hospital, Patna, India
Internal Medicine Residency
2013 · Albert Einstein College of Medicine, Bronx, NY, USA
Cardiovascular Disease Fellowship
2022 · Virginia Commonwealth University Health System, Richmond, VA, USA